浏览全部资源
扫码关注微信
1.武汉市中医医院肺系病科,武汉;430014
2.武汉市第三医院(武汉大学附属同仁医院)急诊医学科,武汉 430014
Published:15 June 2024,
Received:26 October 2023,
Revised:19 March 2024,
扫 描 看 全 文
雷俊,卢丽君,罗玲艳等.吴茱萸碱对哮喘模型大鼠炎症及上皮细胞凋亡的影响及机制 Δ[J].中国药房,2024,35(11):1351-1356.
LEI Jun,LU Lijun,LUO Lingyan,et al.Effects of evodiamine on inflammation and apoptosis of airway epithelial cells in asthma model rats and its mechanism[J].ZHONGGUO YAOFANG,2024,35(11):1351-1356.
雷俊,卢丽君,罗玲艳等.吴茱萸碱对哮喘模型大鼠炎症及上皮细胞凋亡的影响及机制 Δ[J].中国药房,2024,35(11):1351-1356. DOI: 10.6039/j.issn.1001-0408.2024.11.12.
LEI Jun,LU Lijun,LUO Lingyan,et al.Effects of evodiamine on inflammation and apoptosis of airway epithelial cells in asthma model rats and its mechanism[J].ZHONGGUO YAOFANG,2024,35(11):1351-1356. DOI: 10.6039/j.issn.1001-0408.2024.11.12.
目的
2
探究吴茱萸碱对哮喘模型大鼠炎症反应及上皮细胞凋亡的影响及潜在机制。
方法
2
将SD大鼠分为对照组、模型组、吴茱萸碱低剂量组(10 mg/kg)、吴茱萸碱高剂量组(20 mg/kg)、地塞米松组(阳性对照,0.5 mg/kg)、表皮细胞生长因子(EGF)组[丝裂原活化蛋白激酶(MAPK)激活剂,10 μg]、吴茱萸碱高剂量+EGF组(20 mg/kg吴茱萸碱+10 μg EGF),每组10只。除对照组外,其余各组大鼠以10%卵白蛋白(OVA)-氢氧化铝混合液3点注射致敏联合2%OVA雾化液吸入激发的方式建立哮喘模型。检测各组大鼠支气管肺泡灌洗液(BALF)中的炎症细胞(巨噬细胞、淋巴细胞)数,观察大鼠肺组织的病理变化,检测大鼠肺组织中气道上皮细胞凋亡情况、血清炎症因子(肿瘤坏死因子α、白细胞介素6、白细胞介素4)水平、通路相关蛋白[p38 MAPK、磷酸化p38 MAPK(p-p38 MAPK)、信号转导及转录激活因子1(STAT1)]及凋亡相关蛋白[B细胞淋巴瘤2(Bcl-2)、Bcl-2相关X蛋白(Bax)]的表达水平。
结果
2
与对照组比较,模型组大鼠肺组织可见支气管黏膜水肿、肺泡间隔增厚和大量炎症细胞浸润,炎症细胞数显著增多;气道上皮细胞凋亡率、炎症因子水平、p-38 MAPK/p-38 MAPK和Bax、STAT1蛋白表达水平均显著升高,Bcl-2蛋白表达水平和Bcl-2/Bax均显著降低(
P
<0.05)。与模型组比较,吴茱萸碱低、高剂量组和地塞米松组大鼠肺组织病理改变均有不同程度缓解,上述各指标均显著逆转,而EGF组上述指标的变化趋势则相反(
P
<0.05);EGF能显著减弱高剂量吴茱萸碱对哮喘大鼠炎症反应的改善作用(
P
<0.05)。
结论
2
吴茱萸碱可减轻哮喘大鼠炎症反应并减少气道上皮细胞凋亡,其作用机制可能与抑制p38 MAPK/STAT1信号通路有关。
OBJECTIVE
2
To explore the effects and potential mechanism of evodiamine on inflammatory response and apoptosis of epithelial cells in asthma model rats.
METHODS
2
SD rats were separated into control group, model group, evodiamine low-dose group (10 mg/kg), evodiamine high-dose group (20 mg/kg), dexamethasone group (positive control, 0.5 mg/kg), epidermal growth factor (EGF) group [mitogen-activated protein kinase (MAPK) activator, 10 μg], evodiamine high-dose+EGF group (20 mg/kg evodiamine+10 μg EGF), with 10 rats in each group. Except for the control group, the other groups were sensitized by 3-point injection of 10% ovalbumin(OVA)-aluminium hydroxide mixture and stimulated by inhalation of 2%OVA nebulized liquid to establish an asthma model. The count of inflammatory cells (macrophages and lymphocytes) in bronchoalveolar lavage fluid (BALF) was detected in each group; pathological changes of lung tissue in rats were observed; the apoptosis of airway epithelial cells, the levels of serum inflammatory factors [tumor necrosis factor-α, interleukin-6 (IL-6) and IL-4], the expressions of pathway-related proteins p38 MAPK, phosphorylated p38 MAPK (p-p38 MAPK), signal transduction and transcription activating factor 1 (STAT1)] and apoptosis-related proteins [B cell lymphoma-2 (Bcl-2) and Bcl-2 associated X protein (Bax)] were all detected in lung tissue.
RESULTS
2
Compared with the control group, bronchial mucosal edema, thickening of alveolar septa and extensive infiltration of inflammatory cells were observed in the lung tissue of rats in the model group; the number of inflammatory cells, apoptosis rate of airway epithelial cells, the levels of inflammatory factors, p-38 MAPK/p-38 MAPK, and the protein expressions of Bax and STAT1 were increased significantly; the expressions of Bcl-2 protein and Bcl-2/Bax were reduced significantly (
P
<0.05). Compared with the model group, the pathological changes in lung tissues were alleviated to varying degrees in evodiamine low-dose and high-dose groups, and dexamethasone groups, and the above indicators were significantly reversed. However, the change trends of corresponding indicators in the EGF group were opposite to the above (
P
<0.05). EGF could significantly attenuate the effect of high-dose evodiamine on inflammatory response in asthmatic rats (
P
<0.05).
CONCLUSIONS
2
Evodiamine can relieve inflammatory reactions and inhibit the apoptosis of airway epithelial cells in asthmatic rats, the mechanism of which may be associated with inhibiting p38 MAPK/STAT1 signaling pathway.
吴茱萸碱哮喘炎症反应气道上皮细胞凋亡p38 MAPK/STAT1信号通路
asthmainflammationairway epithelial cellsapoptosisp38 MAPK/STAT1 signaling pathway
BUSSE W W. Consequences of severe asthma exacerbations[J]. Curr Opin Allergy Clin Immunol,2023,23(1):44-50.
HEIALY S A,RAMAKRISHNAN R K,HAMID Q. Recent advances in the immunopathogenesis of severe asthma[J]. J Allergy Clin Immunol,2022,149(2):455-465.
CHENG Y T,SUN F,WANG L Y,et al. Virus-induced p38 MAPK activation facilitates viral infection[J]. The- ranostics,2020,10(26):12223-12240.
COLIC E,PATEL P U,KENT O A. Aberrant MAPK signaling offers therapeutic potential for treatment of ovarian carcinoma[J]. Onco Targets Ther,2022,15:1331-1346.
FAN Z W,DONG J J,MU Y D,et al. Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway[J]. Bioengineered,2022,13(6):14670-14681.
MO S Y,DENG H,XIE Y,et al. Chryseriol attenuates the progression of OVA-induced asthma in mice through NF-κB/HIF-1α and MAPK/STAT1 pathways[J]. Allergol Immunopathol,2023,51(1):146-153.
乔连生,郭亦然,张燕玲. 基于片段搜索和相似性搜索的抗哮喘中药发现研究[J]. 中国实验方剂学杂志,2013,19(12):310-314.
QIAO L S,GUO Y R,ZHANG Y L. Fragment and similarity based on virtual screening for anti-asthma traditional Chinese medicine[J]. Chin J Exp Tradit Med Formulae,2013,19(12):310-314.
蹇强,李明月,安建峰,等. 吴茱萸碱通过调控Notch通路抑制Skp2的表达对哮喘小鼠气道重塑和炎症反应的影响[J]. 吉林中医药,2023,43(4):445-450.
JIAN Q,LI M Y,AN J F,et al. Effects of evodialine on the airway remodeling and inflammatory reactions in mice with asthma by regulating the Notch pathway to inhibit the expression of Skp2[J]. Jilin J Chin Med,2023,43(4):445-450.
LIU L Y,WANG H,XENAKIS J J,et al. Notch signaling mediates granulocyte-macrophage colony-stimulating factor priming-induced transendothelial migration of human eosinophils[J]. Allergy,2015,70(7):805-812.
徐增梅,丁伟伟,李泽庚. 麻芍平喘汤对哮喘模型大鼠气道重塑的干预作用[J]. 中医药导报,2020,26(5):23-26.
XU Z M,DING W W,LI Z G. Intervention effect of Mashao pingchuan decoction on airway remodeling in asthmatic model rats[J]. Guid J Tradit Chin Med Pharm,2020,26(5):23-26.
梁磊,张宇婧,李淑娣,等. 搜风愈喘方抑制哮喘大鼠气道重塑的作用机制研究[J]. 中药新药与临床药理,2022,33(1):50-56.
LIANG L,ZHANG Y J,LI S D,et al. The mechanism of Soufeng yuchuan recipe on inhibiting airway remodeling in asthmatic rats[J]. Tradit Chin Drug Res Clin Pharmacol,2022,33(1):50-56.
杨哲,孙荣蔚,王赛男,等. 吴茱萸碱对DSS诱导小鼠急性溃疡性结肠炎的保护作用研究[J]. 中国野生植物资源,2021,40(1):1-8,14.
YANG Z,SUN R W,WANG S N,et al. The protective effects research of evodiamine on acute ulcerative colitis induced by DSS in mice[J]. Chin Wild Plant Resour,2021,40(1):1-8,14.
矫永倩,蒙臣,曾文,等. 表皮生长因子在ARDS小鼠肺组织修复中的作用[J]. 中华麻醉学杂志,2022,42(3):347-353.
JIAO Y Q,MENG C,ZENG W,et al. Role of epidermal growth factor in repair of lung tissues in mice with acute respiratory distress syndrome[J]. Chin J Anesthesiol,2022,42(3):347-353.
CHEN Y H,MEI Y,YANG L,et al. Taxifolin improves inflammatory injury of human bronchial epithelial cells by inhibiting matrix metalloproteinase (MMP) 10 via Wnt/β-catenin pathway[J]. Bioengineered,2022,13(1):1198-1208.
SPITZ A Z,GAVATHIOTIS E. Physiological and pharmacological modulation of BAX[J]. Trends Pharmacol Sci,2022,43(3):206-220.
YE C,ZHANG N,ZHAO Q,et al. Evodiamine alleviates lipopolysaccharide-induced pulmonary inflammation and fibrosis by activating apelin pathway[J]. Phytother Res,2021,35(6):3406-3417.
李俊峰,王重阳,徐畅,等. 隐丹参酮通过抑制p38 MAPK/NF-κB通路改善哮喘气道炎症[J]. 中药新药与临床药理,2020,31(1):15-20.
LI J F,WANG C Y,XU C,et al. Cryptotanshinone alle- viates asthmatic airway inflammation by inhibiting p38 MAPK/NF-κB pathway[J]. Tradit Chin Drug Res Clin Pharmacol,2020,31(1):15-20.
DU L J,TANG L,XIAO L S,et al. Increased expression of CSF1 in patients with eosinophilic asthma[J]. Immun Inflamm Dis,2023,11(5):e847.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution